1. The MAPK Pathway-Based Drug Therapeutic Targets in Pituitary Adenomas
   Miaolong Lu et al, 2019, Frontiers in Endocrinology CrossRef
2. Emerging Roles of miRNA, lncRNA, circRNA, and Their Cross-Talk in Pituitary Adenoma
   Wentao Wu et al, 2022, Cells CrossRef
3. Multiple Endocrine Neoplasia Type 1: The Potential Role of microRNAs in the Management of the Syndrome
   Simone Donati et al, 2020, International Journal of Molecular Sciences CrossRef
4. Up-regulation of the expressions of MiR-149-5p and MiR-99a-3p in exosome inhibits the progress of pituitary adenomas
   Peng Zhao et al, 2021, Cell Biology and Toxicology CrossRef
5. Differences in plasma miRNA levels in inferior petrosal sinus samples of patients with ACTH-dependent Cushing’s syndrome
   A. A. Malygina et al, 2021, Problems of Endocrinology CrossRef
6. MiR-448 targets BLC2 and inhibits the growth of pituitary adenoma cells
   Chao He et al, 2020, Biochemistry and Cell Biology CrossRef
7. Genetics of Pituitary Tumours
   Paul Benjamin Loughrey et al, 2019, Genetics of Endocrine Diseases and Syndromes CrossRef
8. The Emerging Role of Non-Coding RNAs in Pituitary Gland Tumors and Meningioma
   Soudeh Ghafouri-Fard et al, 2021, Cancers CrossRef
9. MicroRNAs as Potential Biomarkers in Pituitary Adenomas
   Simone Donati et al, 2021, Non-Coding RNA CrossRef
10. miR-129-5p and miR-130a-3p Regulate VEGFR-2 Expression in Sensory and Motor Neurons during Development
    Kevin Glaesel et al, 2020, International Journal of Molecular Sciences CrossRef
11. Circulating Noncoding RNAs in Pituitary Neuroendocrine Tumors—Two Sides of the Same Coin
    Henriett Butz, 2022, International Journal of Molecular Sciences CrossRef